July 23, 2024 / 08:52 IST
Reported Standalone quarterly numbers for SOLARA ACTIVE PHARMA SCIENCES are:Net Sales at Rs 363.49 crore in June 2024 up 3.17% from Rs. 352.31 crore in June 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 12.32 crore in June 2024 up 38.03% from Rs. 19.88 crore in June 2023.
EBITDA stands at Rs. 43.62 crore in June 2024 up 105.66% from Rs. 21.21 crore in June 2023.
SOLARA ACTIVE P shares closed at 575.15 on July 22, 2024 (NSE) and has given 49.41% returns over the last 6 months and 46.22% over the last 12 months.
| SOLARA ACTIVE PHARMA SCIENCES | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 363.49 | 299.43 | 352.31 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 363.49 | 299.43 | 352.31 | | EXPENDITURE | | Consumption of Raw Materials | 137.10 | 158.38 | 202.68 | | Purchase of Traded Goods | -- | 0.15 | 1.58 | | Increase/Decrease in Stocks | 64.47 | 1.45 | -12.27 | | Power & Fuel | -- | -- | -- | | Employees Cost | 55.02 | 56.01 | 61.15 | | Depreciation | 25.07 | 25.10 | 25.83 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 64.66 | 73.64 | 80.03 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 17.17 | -15.30 | -6.69 | | Other Income | 1.38 | 1.63 | 2.07 | | P/L Before Int., Excpt. Items & Tax | 18.55 | -13.67 | -4.62 | | Interest | 30.87 | 30.62 | 25.51 | | P/L Before Exceptional Items & Tax | -12.32 | -44.29 | -30.13 | | Exceptional Items | -- | -123.32 | -- | | P/L Before Tax | -12.32 | -167.61 | -30.13 | | Tax | -- | 88.79 | -10.25 | | P/L After Tax from Ordinary Activities | -12.32 | -256.40 | -19.88 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -12.32 | -256.40 | -19.88 | | Equity Share Capital | 40.21 | 36.00 | 36.00 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -3.20 | -71.23 | -5.52 | | Diluted EPS | -3.20 | -71.23 | -5.52 | | EPS After Extra Ordinary | | Basic EPS | -3.20 | -71.23 | -5.52 | | Diluted EPS | -3.20 | -71.23 | -5.52 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
